Your browser doesn't support javascript.
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
Schoch-Spana, Monica; Brunson, Emily K; Long, Rex; Ruth, Alexandra; Ravi, Sanjana J; Trotochaud, Marc; Borio, Luciana; Brewer, Janesse; Buccina, Joseph; Connell, Nancy; Hall, Laura Lee; Kass, Nancy; Kirkland, Anna; Koonin, Lisa; Larson, Heidi; Lu, Brooke Fisher; Omer, Saad B; Orenstein, Walter A; Poland, Gregory A; Privor-Dumm, Lois; Quinn, Sandra Crouse; Salmon, Daniel; White, Alexandre.
  • Schoch-Spana M; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: mschoch1@jhu.edu.
  • Brunson EK; Department of Anthropology, Texas State University, San Marcos, TX, USA.
  • Long R; Department of Anthropology, Texas State University, San Marcos, TX, USA.
  • Ruth A; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Center for Sustainable Health Care Quality and Equity, Washington, DC, USA.
  • Ravi SJ; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Trotochaud M; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Borio L; In-Q-Tel, Arlington, VA, USA.
  • Brewer J; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Buccina J; In-Q-Tel, Arlington, VA, USA.
  • Connell N; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Hall LL; Center for Sustainable Health Care Quality and Equity, Washington, DC, USA.
  • Kass N; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA.
  • Kirkland A; Department of Women's and Gender Studies, University of Michigan, Ann Arbor, MI, USA.
  • Koonin L; Health Preparedness Partners, Atlanta, GA, USA.
  • Larson H; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Lu BF; Department of Communication, University of Maryland, College Park, MD, USA.
  • Omer SB; Yale Institute for Global Health, New Haven, CT, USA; Yale School of Medicine, New Haven, CT, USA; Yale School of Public Health, New Haven, CT, USA.
  • Orenstein WA; Emory Vaccine Center, Atlanta, GA, USA; Emory School of Medicine, Atlanta, GA, USA; Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Privor-Dumm L; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Quinn SC; University of Maryland, School of Public Health, College Park, MD, USA.
  • Salmon D; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • White A; Department of The History of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Center for Medical Humanities and Social Medicine, Johns Hopkins University, Baltimore, MD, USA.
Vaccine ; 39(40): 6004-6012, 2021 09 24.
Article in English | MEDLINE | ID: covidwho-915720
ABSTRACT
Given the social and economic upheavals caused by the COVID-19 pandemic, political leaders, health officials, and members of the public are eager for solutions. One of the most promising, if they can be successfully developed, is vaccines. While the technological development of such countermeasures is currently underway, a key social gap remains. Past experience in routine and crisis contexts demonstrates that uptake of vaccines is more complicated than simply making the technology available. Vaccine uptake, and especially the widespread acceptance of vaccines, is a social endeavor that requires consideration of human factors. To provide a starting place for this critical component of a future COVID-19 vaccination campaign in the United States, the 23-person Working Group on Readying Populations for COVID-19 Vaccines was formed. One outcome of this group is a synthesis of the major challenges and opportunities associated with a future COVID-19 vaccination campaign and empirically-informed recommendations to advance public understanding of, access to, and acceptance of vaccines that protect against SARS-CoV-2. While not inclusive of all possible steps than could or should be done to facilitate COVID-19 vaccination, the working group believes that the recommendations provided are essential for a successful vaccination program.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article